Case number 1:23-cv-01219
Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 1, 2024 | N/A | SO ORDERED, re 17 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries Ltd. answer due 7/26/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 7/26/2024). Signed by Judge Richard G. Andrews on 7/1/2024. (nms) (Entered: 07/01/2024) (0) |
| Jun 28, 2024 | 17 | STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to the Complaint to July 26, 2024 - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) (Entered: 06/28/2024) (2) |
| May 29, 2024 | 16 | STIPULATION and Proposed Order to Extend Time - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 5/29/2024 (nms). (Entered: 05/29/2024) (2) |
| May 29, 2024 | N/A | SO ORDERED, re (D.I. 16 in 23-cv-1219-RGA; D.I. 271 in 21-md-3017-RGA-LDH) STIPULATION and Proposed Order to Extend Time to answer, move or otherwise respond to the Complaint to June 28, 2024. Signed by Judge Richard G. Andrews on 5/29/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 05/29/2024) (0) |
| Apr 29, 2024 | 15 | STIPULATION and Proposed Order to Extend Time to answer, move or otherwise respond to the Complaint to May 29, 2024 - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 4/29/2024 (nms). (Entered: 04/29/2024) (2) |
| Apr 29, 2024 | N/A | SO ORDERED, re (D.I. 15 in 23-cv-1219-RGA; D.I. 261 in 21-md-3017-RGA-LDH) STIPULATION and Proposed Order to Extend Time to answer, move or otherwise respond to the Complaint to May 29, 2024. Signed by Judge Richard G. Andrews on 4/29/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 04/29/2024) (0) |
| Mar 28, 2024 | 14 | STIPULATION and Proposed Order to Extend Time - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Gaza, Anne) Modified on 3/28/2024 (nms). (Entered: 03/28/2024) (2) |
| Mar 28, 2024 | N/A | SO ORDERED, re 14 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries Ltd. answer due 4/29/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 4/29/2024). Signed by Judge Richard G. Andrews on 3/28/2024. (lah) Modified on 3/28/2024 (nms). (Entered: 03/28/2024) (0) |
| Feb 27, 2024 | 13 | STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to March 28, 2024 - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 2/27/2024 (nms). (Entered: 02/27/2024) (2) |
| Feb 27, 2024 | N/A | SO ORDERED, re 13 STIPULATION to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries Ltd. answer due 3/28/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 3/28/2024). Signed by Judge Richard G. Andrews on 2/27/2024. (nms) (Entered: 02/27/2024) (0) |
| Feb 6, 2024 | 12 | STIPULATION to Extend Time - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 2/6/2024 (nms). (Entered: 02/06/2024) (2) |
| Feb 6, 2024 | N/A | SO ORDERED, re 12 STIPULATION to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries Ltd. answer due 2/27/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 2/27/2024). Signed by Judge Richard G. Andrews on 2/6/2024. (nms) (Entered: 02/06/2024) (0) |
| Jan 18, 2024 | N/A | CORRECTING ENTRY: The notice filed at D.I. 11 on 1/18/2024, have been removed from the docket as the filing was incompletely formatted. This case is a member case to MDL 21-3017-RGA, and therefore all filings need to reflect the MDL case in the case caption. Counsel is to amend the notice and refile accordingly. (nms) (Entered: 01/18/2024) (0) |
| Jan 18, 2024 | 11 | NOTICE of Appearance by Anne Shea Gaza on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. (Gaza, Anne) (Entered: 01/18/2024) (4) |
| Jan 17, 2024 | N/A | SO ORDERED, re (D.I. 208 in 21-md-3017-RGA-LDH; D.I. 10 in 23-cv-1219-RGA) STIPULATION to Extend Time to answer, move, or otherwise respond to the Complaint to February 6, 2024. Signed by Judge Richard G. Andrews on 1/17/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 01/17/2024) (0) |
| Jan 16, 2024 | 10 | STIPULATION to Extend Time to answer, move, or otherwise respond to the Complaint to February 6, 2024 - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 1/17/2024 (nms). (Entered: 01/16/2024) (2) |
| Nov 28, 2023 | 8 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Taro Pharmaceutical Industries Ltd. waiver sent on 11/16/2023, answer due 1/16/2024. (Fahnestock, Derek) (Entered: 11/28/2023) (1) |
| Nov 28, 2023 | 9 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Taro Pharmaceuticals U.S.A., Inc. waiver sent on 11/16/2023, answer due 1/16/2024. (Fahnestock, Derek) (Entered: 11/28/2023) (1) |
| Nov 1, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (nms) (Entered: 11/01/2023) (0) |
| Oct 26, 2023 | 1 | Complaint* (1) |
| Oct 26, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 10/26/2023) (3) |
| Oct 26, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/12/2023. Date of Expiration of Patent: 1/31/39. (apk) (Entered: 10/26/2023) (1) |
| Oct 26, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (apk) (Entered: 10/26/2023) (1) |
| Oct 26, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (apk) (Entered: 10/26/2023) (1) |
| Oct 26, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (apk) (Entered: 10/26/2023) (1) |
| Oct 26, 2023 | 7 | Summons Issued as to Taro Pharmaceutical Industries Ltd. on 10/26/2023; Taro Pharmaceuticals U.S.A., Inc. on 10/26/2023. (Attachments: # 1 Summons Issued)(apk) (Entered: 10/26/2023) (0) |
| Oct 26, 2023 | N/A | Remark: MDL Panel has been Notified. (apk) (Entered: 10/26/2023) (0) |
